Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2002, p. 2254-2256, Vol. 46, No. 7
0066-4804/02/$04.00+0 DOI: 10.1128/AAC.46.7.2254-2256.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
McGill University AIDS Centre, Lady Davis Institute-Jewish General Hospital,1 Departments of Microbiology and Immunology,2 Experimental Medicine, McGill University, Montreal, H3T 1E2 Quebec, Canada3
Received 6 November 2001/ Returned for modification 24 January 2002/ Accepted 8 April 2002
We cultured lamivudine-resistant human immunodeficiency virus type 1 (HIV-1) variants over an extended period of time in the presence of zidovudine and observed a premature reversion of the resistance-conferring M184V mutation. These data suggest that the presence of ZDV amplifies differences in replication capacity between wild-type HIV-1 and the mutant variant.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |